Zai Lab registers Phase 3 trial for ZL-1310 in lung cancer and real-world KarXT study in ChinaSep 3Weekly roundup, 2 itemsxanomeline and trospium chlorideZai Lab (Shanghai) Co., Ltd.
BMS registers new deucravacitinib continuation study; prior week's trial results still standAug 27Weekly roundup, 5 itemsBristol Myers Squibbdeucravacitinib
Zai Lab reports Q2 2026 results, advances zoci and ZL-1503 toward key milestonesAug 6Quarterly updateZai Lab (Shanghai) Co., Ltd.ZL-1503
Karuna/BMS opens Phase 3 KarXT relapse prevention trial in schizophreniaJul 7Weekly roundup, 2 itemsBristol Myers Squibbpomalidomide
BMS posts PRIME-HCC results; adds SOTYKTU label update, Phase 3 lung trialJul 2Weekly roundup, 7 itemsBristol Myers Squibbcisplatin
Sign inSign in